AzTrials
AzTrials

Post Operative PainNCT05475795

Postoperative Pain After Pulpectomy of Primary Molars Using Different Obturation Materials

A study testing Metapex and Endoflas in people with Post Operative Pain, run by Minia University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Testing postopertive pain after pulpectomy of primary molars with Metapex and Endoflas using modified Wong-Baker scale of pain. Read more about this study

Who is it for?
Ages 5 to 7 yearsHealthy volunteers can take part
Conditions the study is for
Post Operative Pain
What is being tested?
Metapex and Endoflas
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteEgypt
Study dates
9 Jun 2022to 16 Jan 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 7 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • 3.1. Inclusion criteria: The study will include children who meet the following clinical and radiographic criteria:
  • Clinical:
  • 5-7-year old children categorized as class I or II according to American Society of Anaesthesiologists (ASA) scale.
  • Children rated as no.3 or 4 in Frankel behavior rating scale (FBRS).
  • Presence of at least one primary molar with deep carious lesion.
  • Asymptomatic necrotic molars confirmed by the absence of bleeding on opening of the pulp chamber.
Show all 9Show fewer
  • Radiographic:
  • Extensive caries approaching to the pulp.
  • Presence of at least two-thirds of root length.

Who cannot join

  • A child's tooth with any of the following criteria:
  • Clinical findings:
  • History of spontaneous unprovoked toothache.
  • Extensive crown destruction that preclude coronal restoration.
  • Presence of adjacent or opposing tooth with deep carious lesion "in the same side".
  • History of administering analgesics 12 hours before tooth obturation.
Show all 10Show fewer
  • Radiographic findings:
  • Presence of a large furcation or periapical radiolucency approximating the succedaneous tooth.
  • Presence of pathological internal/external root resorption.
  • Absence of underlying permanent successor.

Trial locations and contacts

1 site in 1 country.

Osama S Gad El-Hak contact

00201023449797

osama.seif@mu.edu.eg

Egypt1 site, 1 recruiting
  • Nada Mohamed Hassan Saied

    Minya, 61511

    Nada M Hassan, 00201116889844, nadooshaa66@gmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: Postoperative Pain After Pulpectomy of Primary Molars Using Different Obturation Materials: A Parallel Randomized Clinical Trial

Testing postopertive pain after pulpectomy of primary molars with Metapex and Endoflas using modified Wong-Baker scale of pain.

Read the detailed description

The current equivalent parallel randomized controlled trial will be conducted to evaluate intensity and duration of post-operative pain after pulpectomy of asymptomatic necrotic primary molars, using Metapex and Endoflas obturation materials

Being tested
Metapex, Endoflas
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MetapexOther

    obturation of root canals of primary molars with Metapex

  • EndoflasOther

    obturation of root canals of primary molars with Endoflas

Study groups in NCT05475795
Study groupRoleWhat they receive
Metapex groupActive comparatorObturation of primary molars with calcium hydroxide and iodoform paste
Receives: Other: Metapex; Other: Endoflas
Endoflas groupExperimentalObturation of primary molars with calcium hydroxide, eugenol and iodoform paste
Receives: Other: Metapex; Other: Endoflas

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. postoperative pain.

    Measuring post operative pain after pulpectomy with two different obturation materials using (Modified Wong-backer scale of pain )which have four scales from( 0 to 3) which 0 is the better outcome( no pain) and 3 is the worst (severe pain).

    Measured: after one day and after one week .

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2022
  2. Study start9 Jun 2022
  3. Primary completion15 Dec 2022 (estimated)
  4. Study completion16 Jan 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05475795
Sponsor's protocol ID
576-2022
Status last verified
Jul 2022
First submitted
24 Jul 2022
Last updated
2 Aug 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Metapex and Endoflas in people with Post Operative Pain, run by Minia University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Osama S Gad El-Hak (00201023449797, osama.seif@mu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

postoperative pain. (time frame: after one day and after one week .). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in